Literature DB >> 21775454

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

Matthieu Perreau1, Hugh C Welles, Alexandre Harari, Olivia Hall, Ricardo Martin, Michel Maillard, Gian Dorta, Pierre-Alexandre Bart, Eric J Kremer, Jim Tartaglia, Ralf Wagner, Mariano Esteban, Yves Levy, Giuseppe Pantaleo.   

Abstract

In the present study, we have investigated the anatomic distribution in blood and gut mucosal tissues of memory poxvirus-specific CD4 and CD8 T cells in subjects vaccinated with smallpox and compared it with vector (NYVAC)-specific and HIV insert-specific T-cell responses induced by an experimental DNA-C/ NYVAC-C vaccine regimen. Smallpox-specific CD4 T-cell responses were present in the blood of 52% of the subjects studied, while smallpox-specific CD8 T cells were rarely detected (12%). With one exception, smallpox-specific T cells were not measurable in gut tissues. Interestingly, NYVAC vector-specific and HIV-specific CD4 and CD8 T-cell responses were detected in almost 100% of the subjects immunized with DNA-C/NYVAC-C in blood and gut tissues. The large majority (83%) of NYVAC-specific CD4 T cells expressed α4β7 integrins and the HIV coreceptor CCR5. These results demonstrate that the experimental DNA-C/NYVAC-C HIV vaccine regimen induces the homing of potentially protective HIV-specific CD4 and CD8 T cells in the gut, the port of entry of HIV and one of the major sites for HIV spreading and the depletion of CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775454      PMCID: PMC3196391          DOI: 10.1128/JVI.00788-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

Authors:  Katherine Masek-Hammerman; Hualin Li; Jinyan Liu; Peter Abbink; Annalena La Porte; Kara L O'Brien; James B Whitney; Angela Carville; Keith G Mansfield; Dan H Barouch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 2.  Poxvirus vector-based HIV vaccines.

Authors:  Giuseppe Pantaleo; Mariano Esteban; Bertram Jacobs; Jim Tartaglia
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 3.  Adenovirus.

Authors:  Jason G Smith; Christopher M Wiethoff; Phoebe L Stewart; Glen R Nemerow
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9.

Authors:  M A Wurbel; J M Philippe; C Nguyen; G Victorero; T Freeman; P Wooding; A Miazek; M G Mattei; M Malissen; B R Jordan; B Malissen; A Carrier; P Naquet
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

5.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

6.  Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.

Authors:  Clayton D Harro; Michael N Robertson; Michelle A Lally; Lori D O'Neill; Srilatha Edupuganti; Paul A Goepfert; Mark J Mulligan; Frances H Priddy; Sheri A Dubey; Lisa S Kierstead; Xiao Sun; Danilo R Casimiro; Mark J DiNubile; John W Shiver; Randi Y Leavitt; Devan V Mehrotra
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

7.  Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

Authors:  Adel Benlahrech; Julian Harris; Andrea Meiser; Timos Papagatsias; Julia Hornig; Peter Hayes; Andre Lieber; Takis Athanasopoulos; Veronique Bachy; Eszter Csomor; Rod Daniels; Kerry Fisher; Frances Gotch; Len Seymour; Karen Logan; Romina Barbagallo; Linda Klavinskis; George Dickson; Steven Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

8.  Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis.

Authors:  B A Zabel; W W Agace; J J Campbell; H M Heath; D Parent; A I Roberts; E C Ebert; N Kassam; S Qin; M Zovko; G J LaRosa; L L Yang; D Soler; E C Butcher; P D Ponath; C M Parker; D P Andrew
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

9.  Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

Authors:  E J Kunkel; J J Campbell; G Haraldsen; J Pan; J Boisvert; A I Roberts; E C Ebert; M A Vierra; S B Goodman; M C Genovese; A J Wardlaw; H B Greenberg; C M Parker; E C Butcher; D P Andrew; W W Agace
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

10.  Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.

Authors:  Kara L O'Brien; Jinyan Liu; Sharon L King; Ying-Hua Sun; Joern E Schmitz; Michelle A Lifton; Natalie A Hutnick; Michael R Betts; Sheri A Dubey; Jaap Goudsmit; John W Shiver; Michael N Robertson; Danilo R Casimiro; Dan H Barouch
Journal:  Nat Med       Date:  2009-07-20       Impact factor: 53.440

View more
  18 in total

1.  Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.

Authors:  Juan García-Arriaza; Beatriz Perdiguero; Jonathan Heeney; Michael Seaman; David C Montefiori; Celia Labranche; Nicole L Yates; Xiaoying Shen; Georgia D Tomaras; Guido Ferrari; Kathryn E Foulds; Adrian McDermott; Shing-Fen Kao; Mario Roederer; Natalie Hawkins; Steve Self; Jiansheng Yao; Patrick Farrell; Sanjay Phogat; Jim Tartaglia; Susan W Barnett; Brian Burke; Anthony Cristillo; Deborah Weiss; Carter Lee; Karen Kibler; Bert Jacobs; Benedikt Asbach; Ralf Wagner; Song Ding; Giuseppe Pantaleo; Mariano Esteban
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 2.  Poxvirus vectors as HIV/AIDS vaccines in humans.

Authors:  Carmen Elena Gómez; Beatriz Perdiguero; Juan Garcia-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 3.  Novel directions in HIV-1 vaccines revealed from clinical trials.

Authors:  Jean-Louis Excler; Georgia D Tomaras; Nina D Russell
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

4.  DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

Authors:  Shuying S Li; Nidhi K Kochar; Marnie Elizaga; Christine M Hay; Gregory J Wilson; Kristen W Cohen; Stephen C De Rosa; Rong Xu; Ayuko Ota-Setlik; Daryl Morris; Greg Finak; Mary Allen; Hong-Van Tieu; Ian Frank; Magdalena E Sobieszczyk; Drew Hannaman; Raphael Gottardo; Peter B Gilbert; Georgia D Tomaras; Lawrence Corey; David K Clarke; Michael A Egan; John H Eldridge; M Juliana McElrath; Nicole Frahm
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

5.  HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.

Authors:  Juan García-Arriaza; Beatriz Perdiguero; Jonathan L Heeney; Michael S Seaman; David C Montefiori; Nicole L Yates; Georgia D Tomaras; Guido Ferrari; Kathryn E Foulds; Mario Roederer; Steven G Self; Bhavesh Borate; Raphael Gottardo; Sanjay Phogat; Jim Tartaglia; Susan W Barnett; Brian Burke; Anthony D Cristillo; Deborah E Weiss; Carter Lee; Karen V Kibler; Bertram L Jacobs; Ralf Wagner; Song Ding; Giuseppe Pantaleo; Mariano Esteban
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

6.  Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.

Authors:  Julie Delaloye; Abdelali Filali-Mouhim; Mark J Cameron; Elias K Haddad; Alexandre Harari; Jean-Pierre Goulet; Carmen E Gomez; Beatriz Perdiguero; Mariano Esteban; Giuseppe Pantaleo; Thierry Roger; Rafick-Pierre Sékaly; Thierry Calandra
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

7.  Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.

Authors:  Peter Hayes; Jill Gilmour; Andrea von Lieven; Dilbinder Gill; Lorna Clark; Jakub Kopycinski; Hannah Cheeseman; Amy Chung; Galit Alter; Len Dally; Devika Zachariah; Angela Lombardo; James Ackland; Eddy Sayeed; Akil Jackson; Marta Boffito; Brian Gazzard; Patricia E Fast; Josephine H Cox; Dagna Laufer
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

8.  Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.

Authors:  Lindsey R Baden; Jinyan Liu; Hualin Li; Jennifer A Johnson; Stephen R Walsh; Jane A Kleinjan; Brian A Engelson; Lauren Peter; Peter Abbink; Danny A Milner; Kevin L Golden; Kyle L Viani; Matthew D Stachler; Benjamin J Chen; Maria G Pau; Mo Weijtens; Brittany R Carey; Caroline A Miller; Edith M Swann; Mark Wolff; Hayley Loblein; Michael S Seaman; Raphael Dolin; Dan H Barouch
Journal:  J Infect Dis       Date:  2014-08-26       Impact factor: 5.226

Review 9.  Pathology-Based Research in Africa.

Authors:  Maria P Lemos; Terrie E Taylor; Suzanne M McGoldrick; Malcolm E Molyneux; Manoj Menon; Steve Kussick; Nonhlanhla N Mkhize; Neil A Martinson; Andrea Stritmatter; Julie Randolph-Habecker
Journal:  Clin Lab Med       Date:  2018-03       Impact factor: 1.935

10.  A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

Authors:  Laura Pattacini; Gregory J Mize; Jessica B Graham; Tayler R Fluharty; Tisha M Graham; Karen Lingnau; Benjamin Wizel; Beatriz Perdiguero; Mariano Esteban; Giuseppe Pantaleo; Mingchao Shen; Gregory A Spies; M Juliana McElrath; Jennifer M Lund
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.